Patents by Inventor Norman Ross
Norman Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100088034Abstract: A system and method approximate a set of wave equations describing the propagation of seismic waves of one or more frequencies through a seismic volume of interest. In one embodiment, a ray-based initial beam solution is determined that describes the propagation of seismic waves at a first frequency through the seismic volume of interest as a set of one or more beams. Based on the ray-based initial beam solution, a refined finite-element beam solution is determined that describes the propagation of the seismic waves at the first frequency through the seismic volume of interest by approximating the two-way wave equation with a one-way wave equation.Type: ApplicationFiled: October 6, 2008Publication date: April 8, 2010Inventor: Norman Ross Hill
-
Publication number: 20090240438Abstract: A system and method that enable the processing of seismic data. In one embodiment, a system comprises a plurality of processing nodes and a server. The plurality of processing nodes are configured to process seismic data for migration. The server is operatively linked to each of the plurality of processing nodes to enable communication between the server and the processing nodes. The server may manage a set of stored beam tables that can be accessed by the processing nodes in order to process seismic data.Type: ApplicationFiled: March 24, 2008Publication date: September 24, 2009Inventors: Yue Wang, Norman Ross Hill
-
Patent number: 6642277Abstract: Disclosed is a plant-derived flavonol-containing dry composition suitable for human consumption, wherein at least 25% of the plant-derived material in the composition comprises polyphenols, together with uses thereof.Type: GrantFiled: January 21, 2000Date of Patent: November 4, 2003Assignee: The Howard FoundationInventors: Alan Norman Howard, Shaja Vijay Nigdikar, Jayshri Rajput-Williams, Norman Ross Williams
-
Patent number: 6514754Abstract: Various genes of herpes virus of turkeys (HVT), Marek's disease virus (MDV) and infectious laryngotracheitis virus (ILTV) have been identified as non-essential regions (and candidates for insertion sites for foreign genes) and/or as antigen-encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TE (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68. Manipulation of these genes allows vaccines to be prepared comprising attenuated virus or virus carrying heterologous antigen-encoding sequences.Type: GrantFiled: May 4, 1999Date of Patent: February 4, 2003Assignee: MerialInventors: Annette Mary Griffin, Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 6413762Abstract: Various genes of herpes virus of turkeys (HVT) Marek's disease virus (MDV) and infectious laryngotracheitis virus (ILTV) have been identified as non-essential regions (and candidates for insertion sites for foreign genes) and/or as antigen-encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TK (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68. Manipulation of these genes allows vaccines to be prepared comprising attenuated virus or virus carrying heterologous antigen-encoding sequences.Type: GrantFiled: December 26, 2000Date of Patent: July 2, 2002Assignee: MerialInventors: Annette Mary Griffin, Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Publication number: 20020042763Abstract: A method for providing trade credit information to a user comprises storing financial information on a memory device, receiving a request from a user for trade credit information regarding a customer of the user, processing the request for trade credit information in conjunction with the stored information, generating a credit report which may include a customer credit limit, a customer credit quote, or a customer credit report, and transmitting the credit report to the user. In preferred embodiments of the invention, the user may also purchase trade credit insurance, monitor a customer account, and/or turn over an account to a collection agency for collection. Each of the embodiments may be purchased by the user as an integrated package or as stand alone modules.Type: ApplicationFiled: June 7, 2001Publication date: April 11, 2002Inventors: Ranjini Pillay, John Salinger, Gretchen Hayes, Simon Ng, Elaine Gubbins, Lisa Margolis, Norman Ross
-
Publication number: 20010024817Abstract: Various genes of herpes virus of turkeys (HVT), Marek's disease virus (MDV) and infectious laryngotracheitis virus (ILTV) have been identified as non-essential regions (and candidates for insertion sites for foreign genes) and/or as antigen-encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TK (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68.Type: ApplicationFiled: December 26, 2000Publication date: September 27, 2001Inventors: Annette Mary Griffin, Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 6099854Abstract: A flavonol-containing dry composition derived from wine and useful as a food supplement is provided wherein at least 25% of the composition derived from wine includes polyphenols and at least 1.0% w/w of the composition is flavonol.Type: GrantFiled: September 19, 1997Date of Patent: August 8, 2000Assignee: The Howard FoundationInventors: Alan Norman Howard, Shailja Vijay Nigdikar, Jayshri Rajput-Williams, Norman Ross Williams
-
Patent number: 6100088Abstract: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK- or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.Type: GrantFiled: December 30, 1998Date of Patent: August 8, 2000Assignee: MerialInventors: Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 6086910Abstract: Disclosed is a flavonol-containing dry composition suitable for human consumption, together with uses thereof.Type: GrantFiled: November 25, 1997Date of Patent: July 11, 2000Assignee: The Howard FoundationInventors: Alan Norman Howard, Shailja Vijay Nigdikar, Jayshri Rajput-Williams, Norman Ross Williams
-
Patent number: 5965435Abstract: Various genes of herpes virus of turkeys (HVT), Marek's disease virus (MDV) and infectious laryngotracheitis virus (ILTV) have been identified as non-essential regions (and candidates for insertion sites for foreign genes) and/or as antigen-encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TK (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68. Manipulation of these genes allows vaccines to be prepared comprising attenuated virus or virus carrying heterologous antigen-encoding sequences.Type: GrantFiled: June 2, 1995Date of Patent: October 12, 1999Assignee: Rhone Merieux S.A.Inventors: Annette Mary Griffin, Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 5958425Abstract: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK- or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.Type: GrantFiled: September 25, 1997Date of Patent: September 28, 1999Assignee: Rhone MerieuxInventors: Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 5906821Abstract: Various genes of herpes virus of turkeys (HVT), Marek's disease virus (MDV) and infectious laryngotracheitis (ILTV) have been identified as non-essential regions (and candidates for insertion sites for foreign genes) and/or as antigen encoding regions. The former include the HVT homologue of the HSV (herpes simplex virus) gC gene, the TK (thymidine kinase) region of MDV or ILTV, ORF3 of ILTV (as defined herein), the ribonucleotide reductase (large subunit) gene of ILTV, MDV or HVT and the ribonucleotide reductase (small subunit) gene of MDV. The antigen-encoding regions include the HVT homologues of the HSV gB, gC and gH genes, the ILTV homologue of HSV gB, ORF2 of ILTV, and the HVT homologue of the HSV-1 immediate early genes IE-175 and IE-68. Manipulation of these genes allows vaccines to be prepared comprising attenuated virus or virus carrying heterologous antigen-encoding sequences.Type: GrantFiled: September 22, 1993Date of Patent: May 25, 1999Assignee: Rhone Merieux S.A.Inventors: Annette Mary Griffin, Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 5840574Abstract: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK- or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.Type: GrantFiled: June 5, 1995Date of Patent: November 24, 1998Assignee: Rhone MerieuxInventors: Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 5744143Abstract: A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK- or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.Type: GrantFiled: May 29, 1996Date of Patent: April 28, 1998Assignee: Rhone MerieuxInventors: Louis Joseph Norman Ross, Simon David Scott, Matthew McKinley Binns
-
Patent number: 5676952Abstract: Herpesviruses naturally deficient in gD, that is to say not expressing their gD gene in vitro or not possessing this gene, are transformed to express gD in vitro. This transformation by genetic recombination can consist in replacement of the natural promoter by another one or insertion of an expression cassette containing gD and a promoter. The invention also relates to these viruses incorporating a gene coding for an antigen of interest, to the vaccines obtained and to the methods of culture thus improved. The invention relates in particular to avian herpesviruses, especially MDV, and the VZV virus.Type: GrantFiled: April 19, 1995Date of Patent: October 14, 1997Assignee: Rhone Merieux, societe anonymeInventors: Jean-Christophe Francis Audonnet, Raphael Jean Darteil, Michel Albert Emile Riviere, Vladimir Zelnik, Louis Joseph Norman Ross
-
Patent number: 5654998Abstract: A laser-excited X-ray source in which the efficiency of conversion of laser energy into X-ray energy, and the average X-ray output power, are increased by providing laser light, which is focussed on a target to generate X-rays, in the form of trains of very short pulses with a pulse duration in the range 1-10 picoseconds. Preferably it is arranged such that successive pulses in a train are focussed at adjacent but different points on the target.Type: GrantFiled: October 30, 1995Date of Patent: August 5, 1997Assignee: Council for the Central Laboratory of the Research CouncilsInventors: Ion Christian Edmond Turcu, Ian Norman Ross, Fergus O'Neill
-
Patent number: 4113388Abstract: Optical apparatus for monitoring the relative positioning of first and second members which are movable relative to each other includes radiation means for generating an optical wavefield which provides, over a given area which has a predetermined location relative to the first member at least when the first member is in a given position relative to the second member, a distinctive light intensity distribution. The distinctive light intensity distribution results from at least two wavefronts that differ from each other in curvature in each of two mutually orthogonal planes. The radiation means preferably includes a source of radiation, a diffracting element and a focussing element. The diffracting element coacts with the source of radiation to provide said at least two wavefronts and the focussing element produces an image of the diffracting element at said predetermined location at least when the first member is in said given position relative to the second member.Type: GrantFiled: June 25, 1976Date of Patent: September 12, 1978Assignee: National Research Development CorporationInventors: John William Charles Gates, Roy Geoffrey Noel Hall, Ian Norman Ross, Richard Frederick Stevens